Skip to content

Released Aug 15, 2011, after the close

10-Q filed Aug 15, 2011, 46 days after period end · 0000950123-11-077641

Q2 2011 · 10-Q
Revenue—
Net Income-$3.75MN/M vs Q2 2010N/M vs Q1 2011
EPS Diluted-$0.10N/M vs Q2 2010N/M vs Q1 2011
Operating Income-$4,622,000N/M
Operating Cash Flowderived-$4,059,000—

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ2 2011Q2 2010
Net Income-$3.75M-$2.14M
EPS Diluted-$0.10-$0.12

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

SELLAS Life Sciences Group, Inc. · CIK 1390478 · Engraved from SEC EDGAR